Ash values and extractive values tell you a crude drug is the right material and reasonably clean. They say nothing about how much active constituent it contains. Standardisation closes that gap, and it works on two levels: a fingerprint that identifies the drug by the pattern of what is present, and an assay that quantifies one marker compound. Monographs require both, and exam questions usually ask you to carry out one and interpret the other.
The TLC fingerprint — identity. Rf is the distance the spot travelled divided by the distance the solvent front travelled, measured from the application line:
Rf = distance moved by spot ÷ distance moved by solvent front
With the solvent front at 7.5 cm, a sample spot at 4.2 cm gives Rf = 4.2 ÷ 7.5 = 0.56, and the authentic marker standard run on the same plate gives Rf = 0.56. A second sample spot at 2.1 cm gives Rf = 0.28.
Three things about that result are examinable. Rf is only comparable within one plate, because it depends on the stationary phase, the mobile phase composition, the chamber saturation and the temperature — which is why the standard and the sample are always run side by side rather than compared against a textbook value. A matching Rf is evidence of identity, not proof; two compounds can co-migrate, so confirmation needs a second mobile phase, a derivatising spray giving a characteristic colour, or a different technique altogether. And the extra spot at Rf 0.28 is information, not noise — the fingerprint is the whole pattern. An authentic drug has a characteristic set of spots, and a sample showing the marker spot but missing the others, or carrying an extra one, is a substitution or adulteration signal even when the assay result is acceptable.
The HPLC assay — content. A marker glycoside is quantified by external standard. The specification used in this exercise is not less than 2.5% w/w.
| Standard solution | 100 µg/mL, peak area 1,250,000 |
|---|
| Sample | 250 mg powdered drug, extracted and made to 25.0 mL, then diluted 1 in 5 |
| Sample peak area | 742,000 |
Step 1 — response factor. 1,250,000 ÷ 100 = 12,500 area units per µg/mL.
Step 2 — concentration in the injected solution. 742,000 ÷ 12,500 = 59.36 µg/mL.
Step 3 — undo the dilution. 59.36 × 5 = 296.8 µg/mL in the extract.
Step 4 — total marker in the extract. 296.8 µg/mL × 25.0 mL = 7,420 µg = 7.42 mg.
Step 5 — express on the drug. 7.42 mg ÷ 250 mg × 100 = 2.97% w/w.
The sample passes, with 2.97% against a floor of 2.5% — about 19% of headroom. Work the calculation in that order, undoing each manipulation in turn, and state the units at every line. The commonest error in this question is forgetting the dilution factor, which gives 0.59% and a confident but wrong conclusion that the batch fails.
Check the chromatography before you trust the number. Quote the relative retention time: a marker eluting at 8.4 minutes against an internal standard at 6.0 minutes gives RRT = 8.4 ÷ 6.0 = 1.40. RRT travels between laboratories and between columns far better than absolute retention time does, so a monograph specifies it rather than "8.4 minutes". Alongside it, confirm resolution from the nearest peak, symmetry, and that the marker peak is pure — a shoulder hidden under it inflates the area and the result with it.
Why the two tests have to be read together. Consider the possibilities:
- Fingerprint matches, assay passes. Authentic drug of acceptable quality. Release it.
- Fingerprint matches, assay fails. Right plant, poor material — harvested at the wrong stage, badly dried, stored too long, or from a low-yielding chemotype. The remedy is sourcing, not rejection of the species.
- Fingerprint does not match, assay passes. The most dangerous combination. The marker is present in sufficient quantity but the pattern is wrong, which happens when a cheaper species is substituted and the extract is spiked with isolated marker compound to meet the specification. An assay alone cannot detect this. The fingerprint is what catches it, and this is the single best argument for why monographs require both.
- Neither matches. Wrong material. Reject and investigate the supplier.
One honest limitation to state. Standardising to a single marker assumes that marker tracks the activity. For most herbal medicines the effect comes from several constituents acting together, and the marker is often chosen because it is easy to measure rather than because it is the active principle. That is why a well-written specification pairs a marker assay with a full fingerprint and, where it exists, a biological assay — and why a good answer says the 2.97% figure certifies consistency of composition, not potency.